Glucose metabolism is impaired in people with Parkinson’s disease


  • People with Parkinson’s disease have impaired glucose metabolism, with greater insulin resistance linked to increased non-motor symptom scores.

Why this matters ?

    These novel findings further our understanding of the pathophysiological link between diabetes and Parkinson’s disease. This connection could prove to be an important therapeutic target with a potential neuroprotective effect of antidiabetic drugs.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.